Joint Formulary & PAD

Epoprostenol sodium - Inhibition of platelet aggregation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
R
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Epoprostenol sodium
Indication :
Inhibition of platelet aggregation
Group Name :
Keywords :
antiplatelet, renal dialysis
Brand Names Include :
Flolan
Important Information :

ITU use only - during renal dialysis if heparin is not suitable

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Epoprostenol sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Inhibition of platelet aggregation.

  • No records returned.